CLINICAL_TRIALS
trial_result
· 2020-07-17
Clinical Trial Update: Trial of TRC105 and Sorafenib in Patients With HCC [Phase 1, Phase 2]
Summary
Clinical trial update for TRC105 plus sorafenib in hepatocellular carcinoma (PHASE 1/2) completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tracon Pharmaceuticals Inc. | Conditions: Hepatocellular Carcinoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-07-17